secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunocore Holdings plc (IMCR)
CIK:        0001671927
Form:       8-K
Filed at:   2024-08-29T23:59:59+00:00
Accession:  0001140361-24-039083
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunocore CFO Brian Di Donato resigns, effective Dec 31, 2024, to become CEO at private biotech
--------------------------------------------------------------------------------

- CFO and Head of Strategy Brian Di Donato resigns effective Dec 31, 2024, to become CEO at a private early-stage biotech in San Diego.
- Resignation not due to any disagreement with Immunocore on financials, internal controls, or policies.
- Di Donato remains through year-end to ensure smooth transition; formal CFO search initiated.
- Di Donato joined over 4 years ago, led IPO and built Finance department.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671927/000114036124039083/0001140361-24-039083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671927/000114036124039083/ef20035097_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-039083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer